Education
About Us
Working with TipRanks
Follow Us
Chee Kong (Peter) Choo Insider Profile
4 Followers
Chee Kong (Peter) Choo, Chairman, Ten Percent Owner at CytoMed Therapeutics Limited, holds 2.39M shares in CytoMed Therapeutics Limited (Ticker: GDTC). Most recently, Chee Kong (Peter) Choo Bought 105,824 shares of CytoMed Therapeutics Limited on Oct 23, 2025 for an estimated value of $283.61K.
Chee Kong (Peter) Choo has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Chee Kong (Peter) Choo's holdings
Insider Roles
Chairman, Ten Percent Owner
Roles that Chee Kong (Peter) Choo holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Chee Kong (Peter) Choo
Chee Kong (Peter) Choo's Trading History
List of latest transactions for each holding click on a transaction to see Chee Kong (Peter) Choo's performance on stock
You May Also Like
Chee Kong (Peter) Choo insider profile FAQ
What is the percentage of profitable transactions made by Chee Kong (Peter) Choo?
The percentage of profitable transactions made by Chee Kong (Peter) Choo is ―.
What is the average return per transaction made by Chee Kong (Peter) Choo?
The average return per transaction made by Chee Kong (Peter) Choo is ―.
What stocks does Chee Kong (Peter) Choo hold?
Chee Kong (Peter) Choo holds: GDTC stocks.
What was Chee Kong (Peter) Choo’s latest transaction?
Chee Kong (Peter) Choo latest transaction was an Informative Buy of $283.61K.
What was Chee Kong (Peter) Choo's most profitable transaction?
Chee Kong (Peter) Choo’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Chee Kong (Peter) Choo's role in CytoMed Therapeutics Limited?
Chee Kong (Peter) Choo's role in CytoMed Therapeutics Limited is Chairman, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.